SCHEMBL1384889

SCHEMBL1384889

Cc1sc(C(=O)O)c2c1[C@H]1[C@@H](C2)C1(C)C.NCc1ccc(OC[C@@H](O)CO)cc1Cl

nearest known ligand 0.61

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 19/20 0.61
S1PR3 Q99500 13/20 0.61
CACNA1G O43497 1/20 0.46
CACNA1H O95180 1/20 0.46
CACNA1I Q9P0X4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1381068 1.00 S1PR1 (0.61) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL6092111 0.88 S1PR1 (0.71) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL2949535 0.87 S1PR1 (0.80) S1PR1S1PR3
SCHEMBL2947493 0.87 S1PR1 (0.80) S1PR1S1PR3
SCHEMBL1383088 0.87 S1PR1 (0.59) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL1381535 0.87 S1PR1 (0.59) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL2944907 0.86 S1PR1 (0.65) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL1381066 0.86 S1PR1 (0.65) S1PR1S1PR3CACNA1GCACNA1HCACNA1I
SCHEMBL6090845 0.84 S1PR1 (0.60) S1PR1S1PR3
SCHEMBL6091352 0.84 S1PR1 (0.60) S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4807884-B2 2011-11-02 JP claimed
EP-1805163-A2 1,1A,5,5A-TETRAHYDRO-3-THIA-CYCLOPROPA¬A|PENTALENES: TRICYCLIC THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS Actelion Pharmaceuticals Ltd. (CH) 2007-07-11 EP claimed
WO-2006010379-A1 NOVEL THIOPHENE DERIVATIVES AS IMMUNOSUPPRESSIVE AGENTS ACTELION PHARMACEUTICALS LTD. (CH) 2006-02-02 WO claimed
WO-2006010544-A2 1, 1A, 5, 5A-TETRAHYDRO-3-THIA-CYCLOPROPA’A! PENTALENES: TRICYCLIC THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2006-02-02 WO claimed